Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 21.0B | 19.5B | 20.8B | 20.7B |
Cost of revenue | 16.9B | 15.5B | 16.9B | 16.8B |
Gross profit | 4.1B | 4.0B | 3.8B | 3.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 288M | 288M | 297M | 332M |
Other operating expenses | 1.3B | 1.4B | 1.4B | 1.2B |
Operating income | 2.5B | 2.3B | 2.2B | 2.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 809M | 807M | 828M | 762M |
Other income expense | 75M | 109M | 170M | 633M |
Pretax income | 1.8B | 1.6B | 1.5B | 2.2B |
Tax provision | 41M | 136M | 89M | 227M |
Net income | 1.7B | 1.4B | 1.4B | 2.0B |
Basic EPS | 0.4 | 0.3 | 0.3 | 0.4 |
Diluted EPS | 0.4 | 0.3 | 0.3 | 0.4 |
Basic average shares | 3.4B | 3.4B | 3.4B | 3.4B |
Diluted average shares | 3.5B | 3.4B | 3.4B | 3.4B |
EBITDA | 3.9B | 3.8B | 3.7B | 3.6B |
Net income from continuing op. | 1.7B | 1.4B | 1.4B | 2.0B |
Minority interests | -397M | -370M | -251M | -678M |
Preferred stock dividends | 67M | 68M | 67M | 131M |